https://thepeptidepipeline.com/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/assets/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/companies/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/trials/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/targets/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/indications/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/modalities/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/catalysts/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/deals/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/readouts/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/approvals/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/reports/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/search/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/data/methodology/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/data/downloads/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/data/changelog/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/newsletter/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/about/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/about/editorial-standards/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/about/data-methodology/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/about/corrections/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/about/funding/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/contact/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/disclaimer/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/privacy/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/terms/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/assets/tirzepatide/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/semaglutide/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/retatrutide/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/cagrisema/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/mazdutide/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/danuglipron/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/lotiglipron/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/survodutide/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/maritide/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/ct-388/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/gsbr-1290/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/orforglipron/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/pemvidutide/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/efinopegdutide/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/assets/oral-semaglutide/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/companies/eli-lilly/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/companies/novo-nordisk/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/companies/pfizer/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/companies/amgen/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/companies/roche/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/companies/boehringer-ingelheim/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/companies/zealand-pharma/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/companies/structure-therapeutics/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/nct03954834/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/nct04184622/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/nct03548935/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/nct05929066/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/nct04159132/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/nct05567796/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/nct05564117/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/pfizer-lotiglipron-ph2/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/roche-ct388-ph1/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/nct05649174/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/structuretx-gsbr1290-ph1/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/trials/lilly-orforglipron-ph3/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/targets/glp-1r/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/targets/gipr/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/targets/glucagon-receptor/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/targets/amylin-receptor/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/targets/somatostatin-receptor/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/indications/type-2-diabetes/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/indications/obesity/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/indications/nash-mash/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/indications/cardiovascular-risk-reduction/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/modalities/linear-peptide/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/modalities/cyclic-peptide/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/modalities/stapled-constrained-peptide/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/modalities/oral-peptide-small-molecule-peptide/ 2026-08-16T07:23:34.597Z https://thepeptidepipeline.com/catalysts/tirzepatide-surmount-mmo-topline/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/catalysts/retatrutide-triumph-readout/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/catalysts/cagrisema-redefine-1-readout/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/catalysts/semaglutide-select-mace-label-expansion/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/catalysts/gsbr-1290-phase-2-readout/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/catalysts/danuglipron-phase-3-start/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/deals/roche-acquires-carmot-therapeutics/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/deals/boehringer-zealand-survodutide-partnership/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/deals/lilly-orforglipron-collaboration/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/deals/novo-nordisk-emisphere-oral-semaglutide/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/readouts/tirzepatide-surpass-2-readout/ 2021-08-05T00:00:00.000Z https://thepeptidepipeline.com/readouts/semaglutide-step-1-readout/ 2021-03-18T00:00:00.000Z https://thepeptidepipeline.com/readouts/retatrutide-phase-2-obesity-readout/ 2023-06-26T00:00:00.000Z https://thepeptidepipeline.com/readouts/amg-133-phase-1-readout/ 2022-12-08T00:00:00.000Z https://thepeptidepipeline.com/approvals/tirzepatide-t2d-fda/ 2022-05-13T00:00:00.000Z https://thepeptidepipeline.com/approvals/semaglutide-obesity-fda/ 2021-06-04T00:00:00.000Z https://thepeptidepipeline.com/approvals/oral-semaglutide-t2d-fda/ 2019-09-20T00:00:00.000Z https://thepeptidepipeline.com/approvals/tirzepatide-obesity-fda/ 2023-11-08T00:00:00.000Z https://thepeptidepipeline.com/reports/glp-1-landscape-2024/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/reports/obesity-market-outlook-2024/ 2024-08-15T00:00:00.000Z https://thepeptidepipeline.com/reports/oral-peptide-competitive-assessment/ 2024-08-15T00:00:00.000Z